Paul Robbins

20PUBLICATIONS
71CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|May 06, 2026
Correlation between recognition of autologous tumor organoids by tumor-infiltrating lymphocytes from metastatic epithelial cancers and clinical response.

|Apr 29, 2026
Vaccination rescues dysfunctional T cell therapy by amplifying rare stem-like antitumor CD8+ T cells.

|Dec 18, 2025
Identification of HLA class II-restricted T cell receptors against shared PIK3CA mutations in patients with epithelial cancers.

S M Rafiqul Islam, Samantha Seitter, Maria Parkhurst

|Jun 13, 2025
Adoptive Cell Transfer of Tumor-Infiltrating Lymphocytes for Metastatic Acral Lentiginous Melanoma.

Paul H McClelland, Shirley K Nah, Alexandra M Gustafson

|Apr 01, 2025
Neoantigen-specific tumor-infiltrating lymphocytes in gastrointestinal cancers: a phase 2 trial.

Frank J Lowery, Stephanie L Goff, Billel Gasmi

|Jan 12, 2025
Utilization of primary tumor samples for cancer neoantigen discovery.

Vid Leko, Eric Groh, Shoshana T Levi

Pageof 4

Frequent Collaborators

15 joint publications

Stephanie L Goff

10 joint publications

Sri Krishna

10 joint publications

James Yang

10 joint publications

Jared J Gartner